Back to Results
First PageMeta Content
Immunology / Macrolides / Transplantation medicine / Kidney transplantation / Organ transplantation / Tacrolimus / Transplant rejection / Immunosuppression / Alemtuzumab / Medicine / Immunosuppressants / Organ transplants


Kidney transplant drug halves the early risk of rejection and allows less toxic treatment
Add to Reading List

Document Date: 2014-10-29 00:21:45

Open Document

File Size: 18,13 KB

Share Result on Facebook

City

San Francisco / /

Country

United States / United Kingdom / /

Facility

Oxford University / /

IndustryTerm

treatment for patients with kidney failure / /

MedicalCondition

cancer / Chronic / kidney failure / infections / /

MedicalTreatment

kidney transplant operation / immunosuppression / Kidney transplant / kidney transplants / Kidney transplantation / /

Organization

Congress / Clinical Trial Service Unit / Oxford University / NHS / Oxford University's Nuffield Department of Surgical Sciences / Medical Research Council / Clinical Trial Service Unit at Oxford University / /

Person

Peter Friend / James Neuberger / Richard Haynes / Colin Baigent / /

Position

Professor / Medical Director / researcher / scientist / Chief Investigator / /

Product

Campath / /

PublishedMedium

The Lancet / /

Technology

transplantation / /

URL

www.tcpdf.org / http /

SocialTag